Bruker Reports Strong Q3, Considerable TOF/TOF Sales to Academic Institutions

Having spilled some of its goodies already in an October presentation at an investors’ meeting (see ProteoMonitor, 10-21-02), Bruker Daltonics formally reported last week that its revenues were up 22 percent for the third quarter. These revenues totaled $29.7 million, compared to $23.8 million in the third quarter of 2001. The company’s net income totaled $1.7 million, up from $925,000 in the previous year’s third quarter.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.